Genmab A (GMAB) Cash from Operations (2018 - 2026)
Genmab A (GMAB) posted Cash from Operations of 3000000.0 for Q1 2026, down 99.66% on a QoQ basis from 885000000.0 in Q3 2025, and down 98.95% year-over-year from 287000000.0 in Q1 2025.
Genmab A (GMAB) Cash from Operations (2018 - 2026) Analysis & Trends
Genmab A's Cash from Operations history runs 6 years deep, the most recent figure standing at 3000000.0 for Q1 2026.
- Quarterly Cash from Operations fell 98.95% year-over-year to 3000000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1524000000.0 (down 9.34% YoY) and the FY2025 annual result came in at 1186000000.0, up 5.33% from the prior year.
- Cash from Operations was 3000000.0 for Q1 2026 at Genmab A, down from 885000000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 885000000.0 in Q3 2025 and bottomed at 3000000.0 in Q1 2026.
- A 3-year average of 416857142.86 and a median of 349000000.0 in 2025 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2025 — Cash from Operations jumped 31.05% — and 2026, when it sank 98.95%.
- Genmab A's Cash from Operations stood at 737000000.0 in 2024, then rose by 20.08% to 885000000.0 in 2025, then plunged by 99.66% to 3000000.0 in 2026.
- Business Quant data shows GMAB's Cash from Operations at 3000000.0 in Q1 2026, 885000000.0 in Q3 2025, and 349000000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Genmab A | 1.89 Bn | 366.92 Mn | 831.00 Mn | 3.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.00 Mn |
| Mar 31, 2026 | 3.00 Mn |
| Sep 30, 2025 | 885.00 Mn |
| Sep 30, 2025 | 885.00 Mn |
| Jun 30, 2025 | 349.00 Mn |
| Jun 30, 2025 | 349.00 Mn |
| Mar 31, 2025 | 287.00 Mn |
| Mar 31, 2025 | 287.00 Mn |
| Sep 30, 2024 | 737.00 Mn |
| Sep 30, 2024 | 737.00 Mn |
| Jun 30, 2024 | 438.00 Mn |
| Jun 30, 2024 | 438.00 Mn |
| Mar 31, 2024 | 219.00 Mn |
| Mar 31, 2024 | 219.00 Mn |
| Sep 30, 2020 | 5,078.00 |
| Sep 30, 2020 | 5,078.00 |
| Dec 31, 2019 | 319.00 |
| Dec 31, 2019 | 319.00 |
| Sep 30, 2019 | 319.07 Mn |
| Sep 30, 2019 | 319.07 Mn |